CT-imaging vs. high-density mapping in ischemic cardiomyopathy VT ablation: in whom do we trust?
Thomas Fink, MD1, Vanessa Sciacca, MD1, Philipp Sommer, MD1
1Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Disclosures: PS is advisory board member of Abbott, Biosense Webster, Boston Scientific and Medtronic.
Funding: (None)